J S Pankow1, P A Decker2, C Berardi3, N Q Hanson4, M Sale5, W Tang1, A M Kanaya6, N B Larson2, M Y Tsai4, C L Wassel7, S J Bielinski2. 1. Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, MN. 2. Department of Health Sciences Research, Mayo Clinic, Rochester, MN. 3. Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY. 4. Department of Laboratory Medicine and Pathology, School of Medicine, University of Minnesota, Minneapolis, MN. 5. Center for Public Health Genomics, University of Virginia, Charlottesville, VA. 6. Department of Medicine, University of California, San Francisco, CA. 7. Department of Pathology and Laboratory Medicine, University of Vermont College of Medicine, Colchester, VT, USA.
Abstract
AIMS: To test the hypothesis that soluble cellular adhesion molecules would be positively and independently associated with risk of diabetes. METHODS: Soluble levels of six cellular adhesion molecules (ICAM-1, E-selectin, VCAM-1, E-cadherin, L-selectin and P-selectin) were measured in participants in the Multi-Ethnic Study of Atherosclerosis, a prospective cohort study. Participants were then followed for up to 10 years to ascertain incident diabetes. RESULTS: Sample sizes ranged from 826 to 2185. After adjusting for age, sex, race/ethnicity, BMI and fasting glucose or HbA1c , four cellular adhesion molecules (ICAM-1, E-selectin, VCAM-1 and E-cadherin) were positively associated with incident diabetes and there was a statistically significant trend across quartiles. Comparing the incidence of diabetes in the highest and lowest quartiles of each cellular adhesion molecule, the magnitude of association was largest for E-selectin (hazard ratio 2.49; 95% CI 1.26-4.93) and ICAM-1 (hazard ratio 1.76; 95% CI 1.22-2.55) in fully adjusted models. Tests of effect modification by racial/ethnic group and sex were not statistically significant for any of the cellular adhesion molecules (P > 0.05). CONCLUSIONS: The finding of significant associations between multiple cellular adhesion molecules and incident diabetes may lend further support to the hypothesis that microvascular endothelial dysfunction contributes to risk of diabetes.
AIMS: To test the hypothesis that soluble cellular adhesion molecules would be positively and independently associated with risk of diabetes. METHODS: Soluble levels of six cellular adhesion molecules (ICAM-1, E-selectin, VCAM-1, E-cadherin, L-selectin and P-selectin) were measured in participants in the Multi-Ethnic Study of Atherosclerosis, a prospective cohort study. Participants were then followed for up to 10 years to ascertain incident diabetes. RESULTS: Sample sizes ranged from 826 to 2185. After adjusting for age, sex, race/ethnicity, BMI and fasting glucose or HbA1c , four cellular adhesion molecules (ICAM-1, E-selectin, VCAM-1 and E-cadherin) were positively associated with incident diabetes and there was a statistically significant trend across quartiles. Comparing the incidence of diabetes in the highest and lowest quartiles of each cellular adhesion molecule, the magnitude of association was largest for E-selectin (hazard ratio 2.49; 95% CI 1.26-4.93) and ICAM-1 (hazard ratio 1.76; 95% CI 1.22-2.55) in fully adjusted models. Tests of effect modification by racial/ethnic group and sex were not statistically significant for any of the cellular adhesion molecules (P > 0.05). CONCLUSIONS: The finding of significant associations between multiple cellular adhesion molecules and incident diabetes may lend further support to the hypothesis that microvascular endothelial dysfunction contributes to risk of diabetes.
Authors: Cecilia Berardi; Nicholas B Larson; Paul A Decker; Christina L Wassel; Phillip S Kirsch; James S Pankow; Michele M Sale; Mariza de Andrade; Hugues Sicotte; Weihong Tang; Naomi Q Hanson; Michael Y Tsai; Yii-Der Ida Chen; Suzette J Bielinski Journal: Hum Genet Date: 2015-01-10 Impact factor: 4.132
Authors: Suzette J Bielinski; James S Pankow; Na Li; Fang-Chi Hsu; Sara D Adar; Nancy Swords Jenny; Donald W Bowden; Bruce A Wasserman; Donna Arnett Journal: Atherosclerosis Date: 2008-03-14 Impact factor: 5.162
Authors: N Sattar; H M Murray; P Welsh; G J Blauw; B M Buckley; A J de Craen; I Ford; N G Forouhi; D J Freeman; J W Jukema; P W Macfarlane; M B Murphy; C J Packard; D J Stott; R G J Westendorp; J Shepherd Journal: Diabetologia Date: 2008-11-22 Impact factor: 10.122
Authors: Dhayana Dallmeier; Martin G Larson; Na Wang; João D Fontes; Emelia J Benjamin; Caroline S Fox Journal: J Am Heart Assoc Date: 2012-08-24 Impact factor: 5.501
Authors: Brian T Steffen; Suzette J Bielinski; Paul A Decker; Cecilia Berardi; Nicholas B Larson; James S Pankow; Erin D Michos; Naomi Q Hanson; David M Herrington; Michael Y Tsai Journal: J Clin Lipidol Date: 2017-06-13 Impact factor: 4.766
Authors: Shohreh F Farzan; Caitlin G Howe; Michael S Zens; Thomas Palys; Jacqueline Y Channon; Zhigang Li; Yu Chen; Margaret R Karagas Journal: Environ Health Perspect Date: 2017-12-15 Impact factor: 9.031